Our History: A Marriage of Social and Commercial Objectives
The Bill & Melinda Gates Foundation and J.P. Morgan created the Global Health Investment Fund (GHIF) in 2012. These organizations sought to test the idea of building an impact investment portfolio from the most promising drug, vaccine, diagnostic, and medical device technologies that address high-burden public health challenges, neglected infectious diseases, and maternal/infant mortality. An emerging track record of success suggests it is possible to have one’s cake and eat it too, as GHIF-backed technologies are increasingly being commercialized at scale and improving public health in historically overlooked markets.
Adjuvant was formed by veterans of the Bill & Melinda Gates Foundation and GHIF as an independent asset management firm designed to scale-up the public health investment model pioneered by this earlier work.